This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Banks 'Potentially At Risk' From Stress Tests

2. Synovus Financial
Shares Synovus Financial (SNV - Get Report) of Columbus, Ga., closed at $1.89 Friday, returning 35% year-to-date, following a 45% decline during 2011.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The shares trade for 0.9 tangible book value, and for 10.5 times the consensus 2013 earnings estimate of 18 cents. The consensus 2012 EPS estimate is 10 cents.

The company owes $967.9 million in federal bailout funds received during 2008 through the Troubled Assets Relief Program, or TARP.

Synovus had $27.1 billion in total assets as of March 31. The company reported first-quarter net income available to common shareholders of $21.4 million, or 2.4 cents a share, compared to earnings to common shareholders of $12.8 million, or 1.4 cents a share in the fourth quarter, and a net loss to common shareholders of $93.7 million, or 11.9 cents a share, during the first quarter of 2011.

Sterne's #2 ranking for Synovus's regulatory risk from the coming stress tests factors-in a tangible common equity ratio of 6.8%, ranking 48th out of 54; and a Texas Ratio of 72.6%, for a 53rd-place ranking.

Hagerman rates Synovus "Underperform," with a $2.00 price target, saying in April that he expects to repay TARP in "2013 at the earliest," and that "although most credit measures continued to show incremental improvement, problem asset levels remain exceedingly high."

The analyst estimates that Synovus will earn five cents a share this year, followed by 2013 EPS of 15 cents.

Interested in more on Synovus Financial? See TheStreet Ratings' report card for this stock.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AF $14.54 1.70%
SNV $31.29 0.61%
TCB $16.33 0.12%
VLY $10.10 0.25%
AAPL $123.38 0.50%

Markets

Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs